Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 10, Number 3—March 2004

Dispatch

Adherence Barriers to Antimicrobial Treatment Guidelines in Teaching Hospital, the Netherlands

Peter G.M. Mol*†Comments to Author , Willem J.M.J. Rutten†, Rijk O.B. Gans†, John E. Degener†, and Flora M. Haaijer-Ruskamp*
Author affiliations: *University of Groningen, Groningen, the Netherlands; †University Hospital Groningen, Groningen, the Netherlands

Suggested citation for this article

Abstract

To optimize appropriate antimicrobial use in a university hospital and identify barriers hampering implementation strategies, physicians were interviewed regarding their opinions on antimicrobial policies. Results indicated that effective strategies should include regular updates of guidelines that incorporate the views of relevant departments and focus on addressing senior staff and residents because residents do not make independent decisions in a teaching-hospital setting.

In an era of increasing bacterial resistance and the availability of a plethora of antimicrobial agents, hospitals have developed policies to promote prudent antimicrobial prescribing (1). The mainstay of such policies is preferably an evidence-based antimicrobial treatment guideline (2). Adherence to such hospital guidelines is often low to moderate (40%–60%) (3,4). Therefore, much effort is put into programs aimed at optimizing the antimicrobial prescribing practices of physicians. To plan an effective intervention strategy, however, one must know the extent to which clinicians perceive the need for a guideline and support implementing that specific guideline (5). The impact of different implementation strategies varies and when, and under what conditions, a particular strategy should be used is often not clear (1,3,4).

We examined barriers that existed in different groups of physicians to the use of a general, hospitalwide antimicrobial treatment guideline. A qualitative approach was chosen to maximize the identification of relevant issues, especially on content and development process of the guideline and physicians’ and organizational characteristics (6,7).

The Study

Physicians were probed on their opinions on antimicrobial policies in general and on aspects of the current antimicrobial treatment guideline and its usefulness in daily clinical practice, using in-depth interviews lasting 20–45 minutes. That antimicrobial treatment guideline was drawn up by the hospitals’ antibiotic use committee, which was composed of specialists of relevant departments. Paper copies of the antimicrobial treatment guideline were distributed hospitalwide, in 1995, with an update in 1999. From the Department of Internal Medicine of the University Hospital, Groningen, physicians were recruited through their chief medical officers in October and November 2001. Interviewees were not paid; all involved were informed that interview-data would be strictly confidential to guarantee interviewees independence. One resident and one supervisor were interviewed from each of six internal medicine subspecialties—intensive care, general internal medicine, pulmonology, gastroenterology, nephrology, and hematology. Residents had 1–6 years of precertification training, and supervisors had been board-certified for 1 to 23 years as a specialist. From the group of infectious disease consultants, two clinical microbiologists and a consulting infectious disease specialist were interviewed. Each interview was concluded with a case-scenario to explore agreement between general opinions on antimicrobial use and response to a specific infectious disease case.

Interviews were audiotaped and transcribed verbatim; the content was analyzed by P.M. and W.R. One recording of an interview with a clinical microbiologist was damaged and could not be used. Recurrent topics were attributed to dominant themes. Important issues and themes emerging from previous interviews were incorporated into subsequent interviews. Themes were classified as barriers related to 1) the guideline, 2) physicians’ characteristics, and 3) characteristics of the institution. Interviewing and analysis were partly simultaneous, which is consistent with the grounded theory approach (8). Physicians were interviewed once. After 15 physicians had been interviewed, no new issues came up, and we stopped interviewing.

Barriers Related to the Guideline

All physicians but one were aware of the guideline, although six never had received a personal copy (Table 1). They suggested that more effort should be put into familiarizing physicians with the guideline. Residents preferred an electronically available copy of the guideline. All physicians agreed with the basic principle of the guideline: an initially empirical antimicrobial treatment should be streamlined to the most narrow-spectrum antimicrobial agent effective against isolated pathogens. Physicians stressed that the guideline needed to be consistent with existing policies, concise, and up-to-date. Supervisors’ expected their own prescribing to be consistent with the guideline, without actually knowing its contents, though residents experienced the opposite: residents experienced that supervisors regularly prescribed or advised them to prescribe antibiotics that were not recommended by the hospital guideline. Infectious disease consultants, as members of the antibiotic use committee, had contradictory views on one aspect of the contents of the guideline. They supported its recommendations for using aminoglycosides when appropriate but were reluctant to advise prescribing them for individual patients.

Barriers Related to Physicians’ Characteristics

Residents were more receptive to using the guideline than were supervisors, especially for rare infectious diseases because they lack experience and have to look up the most effective therapy for a specific condition more often. Junior residents acknowledged a lack of knowledge in interpreting culture and antimicrobial sensitivity test results, resulting in problems with effectively using the guideline based on such tests (Table 1). Infectious disease consultants shared this concern. In contrast to their statements supporting streamlining antimicrobial therapy, residents reported that they were not inclined to change therapy with an effective broad-spectrum antimicrobial agent, once the pathogens’ sensitivity test results became available.

Supervisors did not perceive a strengthened antibiotic policy as an advantage because they considered guidelines a threat to their professional autonomy and as interfering with daily clinical practice. Prescribing an antimicrobial agent was often considered a routine activity. Supervisors doubted the need for an antimicrobial use policy, which was reinforced by the fact that they did not perceive many problems with antimicrobial resistance in daily clinical practice.

At the time of the interviews, a paper “critical-pathway”1 was discussed as a possible decision support tool for improved antimicrobial therapy. Supervisors and residents were negative towards such a tool. Supervisors considered it an unnecessary and unacceptable infringement of daily clinical work, while residents were mostly concerned about the added paperwork. The infectious disease consultants had great trust in a “critical-pathway” to guide antimicrobial drug prescribing, welcoming its educational value and potential for improving actual prescribing behavior.

Social and Institutional Context

Residents in most teaching hospitals are not independent decision makers, and experienced specialists supervise their prescribing choices (Table 1). Residents run the day-to-day clinical care of patients in our hospital; they rotate to different departments at 4-month intervals and have to adapt each time to the mores of a new department or supervisor. They considered the antimicrobial-treatment guideline a helpful tool in coping with existing differences between departments; some departments had their own protocols but mostly discussed antimicrobial use policies informally in departmental patient reviews. The role of the infectious disease consultant was one of adviser. Residents would primarily seek advice from their supervisor, and the final decision is always made by the supervisor.

Case Scenario

To further ascertain the physicians’ use of the antibiotic treatment guideline, we presented a scenario for a case of community-acquired pneumonia (Appendix). All physicians, except for one supervisor, began the patient’s treatment with broad-spectrum antimicrobial agents. Residents were hesitant to streamline initial therapy, fearing that such changed therapy might be clinically less effective. Infectious disease consultants and supervisors streamlined therapy based on gram-stain results only.

Conclusion

Our findings support earlier study findings that an intensive implementation strategy is needed for physicians to make their prescribing practices consistent with guideline recommendations. Table 2 shows the identified barriers along with our suggestions about which interventions might be effective. Any implementation process passes through different stages, each requiring a different intervention approach (9). The supervisors are in an early stage of such a process; they need to be motivated to use the antimicrobial-treatment guideline and to change their prescribing behavior accordingly. Clear involvement in the development of the antimicrobial-treatment guideline may overcome reservations of supervisors with regard to feelings of losing their autonomy. Supervisors see no need to follow the guideline recommendations; they do not perceive antimicrobial resistance as a problem, which may be understandable in view of the low resistance patterns in Dutch hospitals (10). Their routine decision-making leaves little room for guideline consultations. Providing feedback on their own and departmental prescribing patterns may identify areas to be improved and raise awareness of a need to change (11,12). The usefulness of the guidelines could be emphasized for nonroutine cases, about which physicians were less reluctant to consult the guideline.

Residents are more open to using the guidelines; they are willing to adopt the recommendations because it helps them in their learning process, making them ideal candidates for interventions. For them, the barrier to be addressed is whether streamlining is safe. One way of affirming this is facilitating a better understanding of culture and sensitivity tests, for example, through infectious disease consultants’ support (6). As paper critical-pathways will not suffice, face-to-face educational visits, so-called academic detailing, may be a better way to improve residents’ prescribing practices (13). Academic detailing should focus not only on interpretation of test results but also on acting on the implications. Infectious disease consultants should be motivated to give advice consistent with the guideline.

In an institutional context where residents are not independent decision makers, any implementation plan should combine strategies aimed at both residents and supervisors. For residents who change departments regularly, a generally adopted hospitalwide guideline facilitates a consistent learning environment and increase their rational decision making. Addressing the role model function of supervisors for residents may be one more way to motivate them to use the guideline, in view of the impact that supervisors have on residents (14).

The limited number of physicians interviewed in this study is in line with a qualitative research approach aimed at generating hypotheses (15). We found physicians to be very open in expressing their, sometimes negative, views during the interview sessions. Residents were quite frank about their relationship with their supervisors, possibly because the interviewer had no direct link to any chief medical officer and confidentiality was assured.

In conclusion, intervention strategies should focus on improving dissemination and credibility of the recommendations, focusing on both supervisors and residents, although each group needs a tailored approach. Active outreach, as in face-to-face educational visits, may be the best approach to tackling the various barriers in one intervention program aimed at optimizing antimicrobial use.

Dr. Mol is a junior researcher at the Department of Clinical Pharmacology at the University of Groningen, with a research interest in antimicrobial use in hospitals. He has worked in a community-pharmacy in the Netherlands and as a regional pharmacist in Namibia.

Acknowledgment

This study was part of a larger intervention study sponsored by an unconditional grant from the board of the University Hospital Groningen and the Health Care Insurance Board, the Netherlands.

References

  1. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999;43:45965. DOIPubMed
  2. Fijn R, Chow MC, Schuur PM, De Jong-Van den Berg LT, Brouwers JR. Multicentre evaluation of prescribing concurrence with anti-infective guidelines: epidemiological assessment of indicators. Pharmacoepidemiol Drug Saf. 2002;11:36172. DOIPubMed
  3. Halm EA, Atlas SJ, Borowsky LH, Benzer TI, Metlay JP, Chang YC, Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med. 2000;160:98104. DOIPubMed
  4. van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother. 2002;49:6616. DOIPubMed
  5. Grol R. Personal paper: beliefs and evidence in changing clinical practice. BMJ. 1997;315:41821.PubMed
  6. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC, Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:145865. DOIPubMed
  7. Tunis SR, Hayward RS, Wilson MC, Rubin HR, Bass EB, Johnston M, Internists’attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:95663.PubMed
  8. Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park (CA): Sage Publications; 1990.
  9. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12:3848.PubMed
  10. Bronzwaer SLAM, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen Ir K, European sdy on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:27882. DOIPubMed
  11. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:4658.PubMed
  12. Denig P, Witteman CLM, Schouten HW. Scope and nature of prescribing decisions made by general practicioners. Qual Health Care. 2002;11:13743. DOI
  13. Soumerai SB, Avorn J. Principles of Educational outreach (“academic detailing”) to improve clinical decision making. JAMA. 1990;263:54956. DOIPubMed
  14. Paice E, Heard S, Moss F. How important are role models in making good doctors? BMJ. 2002;325:70710. DOIPubMed
  15. Dixon-Woods M, Fitzpatrick R. Qualitative research in systematic reviews. Has established a place for itself. BMJ. 2001;323:7656. DOIPubMed

Tables

Suggested citation: Mol PGM, Rutten WJMJ, Gans ROB, Degener JE, Haaijer-Ruskamp FM. Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis [serial online] 2004 Mar [date cited]. Available from: http://wwwnc.cdc.gov/eid/article/10/3/03-0292.htm

DOI: 10.3201/eid1003.030292

1A paper “critical-pathway” combines an antimicrobial drug order form with a decision support tool. Filling out a few relevant case-characteristics guides the prescriber to the guideline’s recommendation for that specific case.

Top of Page

Table of Contents – Volume 10, Number 3—March 2004

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Peter G.M. Mol, Department of Clinical Pharmacology, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands; fax: + 31-50-3632812





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO